Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACHL | AMGN | VRTX | REGN | GILD |
| Company | Achilles Therapeutics Plc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8506 | 330.46 | 493.25 | 1,087.89 | 70.33 |
| High | 0.8799 | 335.91 | 496.93 | 1,100.08 | 72.05 |
| Low | 0.8153 | 328.00 | 488.09 | 1,079.08 | 70.33 |
| Last | 0.8579 | 333.14 | 488.98 | 1,094.99 | 71.64 |
| Change | +0.0190 | +2.99 | -1.87 | +12.88 | +0.83 |
| % Change | +2.26% | +0.91% | -0.38% | +1.19% | +1.17% |
| Volume | 51,900 | 1,879,400 | 813,100 | 282,300 | 5,129,600 |
| 20-Day Average Volume | 53,895 | 2,394,770 | 1,181,020 | 480,730 | 8,637,885 |
| Previous Close | 0.8389 | 330.15 | 490.85 | 1,082.11 | 70.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8419 | 315.70 | 477.76 | 1,059.15 | 68.52 |
| 20-Day Raw Stochastic | 55.09% | 92.96% | 76.41% | 88.18% | 94.31% |
| 20-Day Relative Strength | 49.01% | 69.93% | 64.47% | 66.10% | 63.12% |
| Weighted Alpha | -10.50 | +41.65 | +39.89 | +49.31 | -9.32 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Last Month's Opinion | 40% Sell | 88% Buy | 100% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.72% since 07/09/24 | +5.45% since 07/09/24 | +0.62% since 07/09/24 | +3.89% since 07/09/24 | +5.73% since 07/09/24 |
| Low | 0.8050 on 07/10/24 | 314.64 on 07/10/24 | 485.77 on 07/10/24 | 1,053.28 on 07/10/24 | 67.65 on 07/10/24 |
| High | 0.9094 on 07/12/24 | 335.91 on 07/16/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 72.05 on 07/16/24 |
| 1-Month | |||||
| %Chg | -4.89% since 06/14/24 | +11.56% since 06/14/24 | +1.72% since 06/14/24 | +5.64% since 06/14/24 | +10.11% since 06/14/24 |
| Low | 0.7940 on 06/28/24 | 296.56 on 06/17/24 | 463.23 on 06/20/24 | 1,011.67 on 07/03/24 | 62.69 on 06/18/24 |
| High | 0.9100 on 06/18/24 | 335.91 on 07/16/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +6.94% since 04/16/24 | +25.41% since 04/16/24 | +24.05% since 04/16/24 | +22.46% since 04/16/24 | +6.43% since 04/16/24 |
| Low | 0.7400 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.9703 on 05/10/24 | 335.91 on 07/16/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -2.60% since 01/16/24 | +9.77% since 01/16/24 | +11.77% since 01/16/24 | +16.82% since 01/16/24 | -16.69% since 01/16/24 |
| Low | 0.7400 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.7600 on 02/29/24 | 335.91 on 07/16/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,469 | 177,104,016 | 126,665,320 | 119,233,360 | 88,218,848 |
| Shares Outstanding, K | 41,088 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -69,670,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -12,270,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.32 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/02/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.76 | 32.45 | 29.64 | 17.36 |